Price & volume screen · refreshed after the Nov 12, 2026 close
Most volatile stocks: Healthcare
Companies with the widest daily price swings over the last 60 sessions. Annualised standard deviation of daily returns over 60 sessions. Higher volatility means bigger moves in both directions.
| # | Company | Price | Today | Volatility 60d | 1M | Mkt cap |
|---|---|---|---|---|---|---|
| 351 | ANIPANI PharmaceuticalsHealthcare | $71.06 | −0.04% | 29.2% | +1.3% | $1.62B |
| 352 | EHCEncompass HealthHealthcare | $140.83 | −0.99% | 29.0% | +11.3% | $13.82B |
| 353 | BIIBBiogenHealthcare | $250.48 | −1.15% | 28.8% | +7.6% | $37.03B |
| 354 | EXELExelixisHealthcare | $69.84 | −1.22% | 28.8% | +14.5% | $17.04B |
| 355 | INVAInnovivaHealthcare | $18.97 | +0.58% | 28.8% | −9.5% | $1.35B |
| 356 | TEVATeva Pharmaceutical Industries LimitedHealthcare | $43.65 | +0.95% | 28.7% | +7.2% | $50.93B |
| 357 | USPHUS Physical TherapyHealthcare | $98.60 | −1.50% | 28.6% | +16.1% | $1.47B |
| 358 | MRKMerck & Co.Healthcare | $146.95 | −0.16% | 28.2% | −0.3% | $362.27B |
| 359 | BMYBristol-Myers SquibbHealthcare | $62.32 | −0.94% | 27.8% | +5.1% | $127.39B |
| 360 | LHLabcorp HoldingsHealthcare | $372.32 | +0.02% | 27.8% | +17.3% | $30.23B |
| 361 | TFXTeleflex IncorporatedHealthcare | $153.15 | −2.03% | 27.7% | +24.2% | $6.07B |
| 362 | CONConcentra Group Holdings ParentHealthcare | $42.99 | −1.06% | 27.7% | +14.8% | $5.40B |
| 363 | PRVAPrivia Health GroupHealthcare | $23.67 | −1.54% | 27.5% | +9.2% | $3.02B |
| 364 | WATWatersHealthcare | $462.20 | −1.85% | 27.4% | +5.9% | $90.84B |
| 365 | MDTMedtronicHealthcare | $100.99 | −0.61% | 27.2% | +7.2% | $129.18B |
| 366 | GILDGilead SciencesHealthcare | $167.95 | −1.05% | 27.2% | +9.4% | $208.31B |
| 367 | BMRNBioMarin PharmaceuticalsHealthcare | $56.70 | −2.79% | 26.9% | +2.8% | $10.98B |
| 368 | MDPediatrix Medical GroupHealthcare | $31.40 | −0.16% | 26.9% | +16.0% | $2.45B |
| 369 | VTRSViatrisHealthcare | $20.67 | −1.85% | 26.2% | +18.5% | $23.70B |
| 370 | ABTAbbott LaboratoriesHealthcare | $107.25 | −1.87% | 25.8% | +4.2% | $185.75B |
| 371 | VRTXVertex PharmaceuticalsHealthcare | $542.62 | −0.81% | 25.8% | +8.9% | $137.57B |
| 372 | STESTERISHealthcare | $253.44 | −1.10% | 25.6% | +16.7% | $24.61B |
| 373 | MTDMettler-Toledo InternationalHealthcare | $1,730.93 | −1.03% | 25.6% | +7.6% | $34.43B |
| 374 | SOLVSolventumHealthcare | $88.81 | +0.21% | 25.5% | +1.8% | $15.09B |
| 375 | EWEdwards LifesciencesHealthcare | $105.80 | −0.01% | 25.3% | +22.4% | $60.84B |
| 376 | MSAMine Safety IncorporatedHealthcare | $174.61 | −0.92% | 24.9% | −3.8% | $6.73B |
| 377 | JNJJohnson & JohnsonHealthcare | $283.52 | +1.11% | 24.5% | +11.7% | $682.52B |
| 378 | MOVMovado GroupHealthcare | $31.95 | −1.90% | 24.1% | −0.8% | $712.9M |
| 379 | RPRXRoyalty PharmaHealthcare | $68.97 | −1.49% | 23.9% | +16.9% | $30.71B |
| 380 | BDXBecton, Dickinson andHealthcare | $215.71 | +0.55% | 23.7% | +14.2% | $58.76B |
| 381 | CHEChemedHealthcare | $550.20 | −0.08% | 23.2% | +7.2% | $7.13B |
| 382 | WSTWest Pharmaceutical ServicesHealthcare | $411.30 | −0.38% | 22.5% | +9.8% | $28.65B |
| 383 | DGXQuest DiagnosticsHealthcare | $259.65 | +0.37% | 21.8% | +11.2% | $28.57B |
| 384 | ADUSAddus HomeCareHealthcare | $123.72 | −1.41% | 20.4% | +6.1% | $2.31B |
| 385 | PFEPfizerHealthcare | $28.83 | −2.11% | 20.3% | −1.3% | $164.33B |
| 386 | ABBVABBVIEHealthcare | $294.45 | −0.18% | 20.0% | +3.9% | $520.47B |
| 387 | PENPenumbraHealthcare | $320.77 | −0.30% | 7.9% | +0.2% | $12.64B |
| 388 | LNTHLantheus HoldingsHealthcare | $101.25 | −0.34% | 4.2% | +1.3% | $6.62B |
| 389 | OGNOrganon &Healthcare | $13.90 | +0.07% | 3.0% | +1.2% | $3.65B |
| 390 | ITGRInteger HoldingsHealthcare | $126.42 | −0.21% | 2.3% | −0.2% | $4.30B |
| 391 | TECHBio-TechneHealthcare | $72.84 | +0.05% | 1.9% | +0.5% | $11.44B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.